PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-04-28

Date Title Company
28-Apr-2020 BerGenBio's Bemcentinib Selected to Be Fast-tracked As Potential Treatment for COVID-19 Through New National UK Government Clinical Trial Initiative BerGenBio ASA
28-Apr-2020 RHÖN-KLINIKUM Aktiengesellschaft: Management board decides to convene an extraordinary virtual general meeting on 3 June 2020 and postpone the ordinary general meeting; court application by B. Braun for authorization to convene the general meeting RHÖN-KLINIKUM Aktiengesellschaft
28-Apr-2020 Counties Set To Launch Free Prescription Assistance Program United Networks of America; County Executives of America
28-Apr-2020 ArcherDX and UCL Present New Minimal Residual Disease Surveillance Data from their Collaboration at 2020 AACR Virtual Annual Meeting ArcherDX
28-Apr-2020 Valo Therapeutics to Support Development of a Pan – Coronavirus Vaccine Valo Therapeutics
28-Apr-2020 SHIONOGI RECEIVES EUROPEAN COMMISSION MARKETING AUTHORISATION FOR FETCROJA® (CEFIDEROCOL) FOR THE TREATMENT OF INFECTIONS DUE TO AEROBIC GRAM-NEGATIVE BACTERIA IN ADULTS WITH LIMITED TREATMENT OPTIONS Shionogi & Co., Ltd
28-Apr-2020 COVID-19 Could Reshape Mental Health Treatment Flow Neuroscience
28-Apr-2020 MARINOMED RECEIVES FFG FUNDING TO RESEARCH SARS-CoV-2 THERAPY BASED ON CARRAGELOSE® Marinomed Biotech AG
28-Apr-2020 MR Solutions now offers the widest range of preclinical nuclear medicine imaging systems MR Solutions
28-Apr-2020 Healthcare Communications Volunteers Website Launched by HCA Healthcare Communications Association (HCA)
28-Apr-2020 OBN Announces the Launch of OBN Ventures™ OBN
28-Apr-2020 Sanofi and Regeneron provide update on U.S. Phase 2/3 adaptive-designed trial in hospitalized COVID-19 patients Sanofi
28-Apr-2020 Six COVID-19 Patients Treated with RedHill’s Opaganib Under Compassionate Use Show Objective Clinical Improvement RedHill Biopharma
28-Apr-2020 Orgenesis completes acquisition of Tamir Biotechnology, Inc. assets including broad spectrum antiviral platform Orgenesis
28-Apr-2020 Protecting Consumer Safety and Driving Efficiencies with Centralised Label Management NiceLabel
28-Apr-2020 South Wales business secures £226 million from HSBC UK to support essential industries during Covid-19 HSBC Holdings plc
28-Apr-2020 Medical Realities launches a free digital online resource to train 1m healthcare workers for COVID-19 Medical Realities
28-Apr-2020 Restoration of NHS services is about reset not just recovery NHS services
28-Apr-2020 Insilico and Astellas collaborate on AI for a conventionally challenging target family Insilico Medicine
28-Apr-2020 NICE RECOMMENDS STELARA® (USTEKINUMAB) FOR THE TREATMENT OF MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS The Janssen Pharmaceutical Companies of Johnson & Johnson